Statement of Changes in Beneficial Ownership (4)
November 12 2014 - 8:01AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Shao Sean
|
2. Issuer Name
and
Ticker or Trading Symbol
China Biologic Products, Inc.
[
CBPO
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
21ST FLOOR, EVERBRIGHT BANK BUILDING, ZHUZILIN, FUTIAN DISTRICT
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
11/10/2014
|
(Street)
SHENZHEN, GUANGDONG, F4 100125
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common stock
|
11/10/2014
|
|
M
(1)
|
|
40000
(1)
|
A
|
$12.26
|
62500
|
D
|
|
Common stock
|
11/10/2014
|
|
M
(1)
|
|
30000
(1)
|
A
|
$16.39
|
92500
|
D
|
|
Common stock
|
11/10/2014
|
|
S
(1)
|
|
40000
(1)
|
D
|
$62.75
|
52500
|
D
|
|
Common stock
|
11/10/2014
|
|
S
(1)
|
|
30000
(1)
|
D
|
$62.75
|
22500
|
D
|
|
Common stock
|
11/10/2014
|
|
S
|
|
2500
|
D
|
$62.75
|
20000
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Option (right to buy)
(2)
|
$12.26
|
11/10/2014
|
|
M
|
|
|
40000
|
10/11/2010
|
7/11/2020
|
Common stock
|
40000
|
(2)
|
30000
|
D
|
|
Stock Option (right to buy)
(3)
|
$16.39
|
11/10/2014
|
|
M
|
|
|
30000
|
4/1/2011
|
1/1/2021
|
Common stock
|
30000
|
(3)
|
0
|
D
|
|
Explanation of Responses:
|
(
1)
|
Represents an aggregate of 70,000 shares of common stock (the "Sold Common Stock") sold on the open market for $62.75 per share on November 10, 2014. The Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnotes 2 and 3 below for further details on the relevant stock options.
|
(
2)
|
Represents previously reported stock options to purchase 40,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated July 11, 2010. The options will vest in equal portions on a quarterly basis over a 3-year period, with the first portion to vest on October 11, 2010.
|
(
3)
|
Represents previously reported stock options to purchase 30,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated January 1, 2011. The options will vest in equal portions on a quarterly basis over a 12-month period, with the first portion to vest on April 1, 2011.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Shao Sean
21ST FLOOR, EVERBRIGHT BANK BUILDING
ZHUZILIN, FUTIAN DISTRICT
SHENZHEN, GUANGDONG, F4 100125
|
X
|
|
|
|
Signatures
|
/s/ Sean Shao
|
|
11/12/2014
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jul 2023 to Jul 2024